Article
Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional Study
8 Jul 2019
Abstract excerpt
Significance Statement About 1% of the population is heterozygous for loss-of-function variants in SLC12A3 , which encodes the thiazide-sensitive sodium-chloride cotransporter. Biallelic SLC12A3 mutations are responsible for Gitelman syndrome, a salt-losing tubulopathy. In a cross-sectional study of 81 heterozygous carriers, 82 healthy noncarriers, and 79 patients with Gitelman syndrome of similar age, body mass...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
